Globe Newswire
#FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be... (continue reading...)MammoLink joins Mammogen’s KATELYN-ERIN trial, expanding community access to a prospective study evaluating blood-based RNA biology for breast cancer detection
NEWPORT BEACH, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Mammogen, a predictive health company pioneering blood-based RNA diagnostics for women’s health, today announced a clinical research partnership with MammoLink, a specialized women’s health imaging provider founded by breast imaging radiologist Dr. Ryan... (continue reading...)
TORONTO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide an update on the advancement of key development activities at its 100%-owned and fully permitted Goldboro Gold Project in Nova Scotia (“Goldboro” or the “Project”) through mid-October 2026.
Kevin Bullock, President, CEO & Director of NexGold, commented: “As we move closer to a potential construction decision on Goldboro, we... (continue reading...)
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be... (continue reading...)CARMEL, Ind., Oct. 27, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report summarized financial results for its third quarter period ended September 30, 2026, on Monday, November 9, 2026, before market open. The Company has scheduled a conference call for the same day,... (continue reading...)
More Globe Newswire
View Older Stories-
Anfield Energy Receives Draft Renewed Radioactive Materials License and Draft Groundwater Discharge Permit for Shootaring Canyon Mill from Utah DWMRC
-
Media Advisory: MADD Canada’s Project Red Ribbon to Honour Two Pillars of the Bangladeshi Community
-
George Weston Limited Announces Timing of Third Quarter Earnings Release
-
OutSolve Acquires Legets, Adding AI Horsepower to its HR Compliance as a Service Solution
-
Repligen Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
-
Questor Appoints Audrey Mascarenhas President and Chief Executive Officer
-
Bioventus to Report Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026
-
The Simply Good Foods Company Reports Fiscal Fourth Quarter and Full Fiscal Year 2026 Financial Results and Provides Fiscal Year 2027 Outlook
-
Global Financial News from MT Newswires Now Live in Microsoft Copilot
-
Presenting on Emerging Growth Conference 97 Day 1 on October 28; Register to live stream
-
Tonix Pharmaceuticals Presented an Analysis of Phase 3 Data Demonstrating TONMYA® Improved Physical Symptoms and Functional Ability of Patients with Fibromyalgia at the IASP 2026 World Congress on Pa
-
Manual Links Marks Five Years as a Manual Link Building Service, With More Than 300 SaaS and Healthcare Brands Served
-
Luckin Coffee to Announce Third Quarter 2026 Financial Results on November 3, 2026
-
SunPower Expands in Texas with SOLRITE Virtual Power Plant Partnership
-
Foremost Reports Assay Results from Tuning Fork Uranium Zone Including High-Grade Highlight of 1.3% U₃O₈ over 1.0 Metre
-
Aeluma to Participate in Upcoming Investor Conferences
-
Osisko Gold Provides Construction Progress Update on the Cariboo Gold Project
-
Ashland sets date for fourth-quarter fiscal 2026 earnings release and conference call webcast
-
ButcherBox Takes a Stand on Antibiotics in School Meals on Capitol Hill
-
Beam Therapeutics Reports Initial Clinical Data from Phase 1/2 Trial of BEAM-301, Demonstrating Proof of Concept for Genetic Correction in Glycogen Storage Disease Type Ia (GSDIa) at ESGCT 33rd Annual
-
Factorial Sets Date for Third Quarter 2026 Results
-
Iovance Biotherapeutics to Report Third Quarter 2026 Financial Results and Corporate Updates on Thursday, November 5, 2026
-
TransMedics selects Gogo Galileo HDX for nationwide organ transport fleet
-
Fortrea to Participate in Jefferies Global Healthcare Conference
-
Cullinan Therapeutics Advances Velinotamig into Global Clinical Development for Autoimmune Cytopenias Following IND Clearance by the U.S. FDA
-
Satellos Establishes Scientific Advisory Board to Explore the Biology of Regeneration in Aging and Neuroscience
-
Arvinas to Report Third Quarter 2026 Financial Results on November 3, 2026
-
Aquestive Therapeutics to Report Third Quarter 2026 Financial Results and Recent Business Highlights on November 3 and Host Conference Call on November 4 at 8:00 a.m. ET
-
GXO Opens Strategic Logistics Hub in Malaysia to Support Growth Across Asia Pacific
-
MEGL Enters into Strategic Cooperation with Singapore’s SIN HOPEWAY for USD 500 Million Timber Trade
-
Adagene to Participate in the Guggenheim Securities 3rd Annual Healthcare Innovation Conference
-
Marex appoints Kory Sorenson to Group Board
-
CoinShares Board Approve $40 Million Share Repurchase Program
-
SNDL Reports Third Quarter 2026 Financial and Operational Results
-
YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
-
DNOW Announces Third Quarter 2026 Earnings Conference Call
-
Herschel Parts Automates Multicarrier Shipping and Improves Cost Control with Descartes
-
Aclaris Therapeutics Announces Pricing of $50.0 Million Offering of Common Stock and Pre-Funded Warrants
-
Marathon Feet Trace China Tianjin's Stories as 30,000 Runners Hit the Streets
-
Bosideng Marks 50 Years with ‘Warmth Code’ Exhibition in Shanghai
-
Marathon Feet Trace China Tianjin's Stories as 30,000 Runners Hit the Streets
-
DSV, 1179 - SHARE BUYBACK IN DSV A/S
-
INNIO Reports Record Third Quarter 2026 Financial Results with Revenue Up 57%, Net Income Up 176% and Adjusted EBITDA Up 70%; Raises 2026 Full-Year Guidance
-
Acme United Reports Third Quarter 2026 Net Sales Increase of 18%
-
Midnight Sun’s Dumbwa Copper Deposit More Than Doubles in Width to Over 2.4 km in Northern Block
-
Akamai Launches AI Inference Service and Agent Execution Environment
-
Zacatecas Silver Reports High-Grade Gold and Silver Rock Chip Sampling at Cumaro, Sonora, with Assays up to 40.6 g/t Gold and 253 g/t Silver
-
Merakris Advances Potentially Pivotal MTX-001 Phase 2/3 Strategy Following FDA Pre-IND Meeting
-
Nova Minerals Secures Final Permits for Alaska Antimony Project, Clearing Path to 2027 Production
-
Sigenergy Unveils SigenCube at Exclusive Melbourne VIP Gala Ahead of All-Energy Australia 2026
